一种名为JS K的一氧化氮 (NO)前药已证明可选择性杀死NO敏感性白血病细胞 ,而对健康细胞无损害。这有望作为发展新一代抗癌药的先导化合物。NO类结构简单、功能多样的生物活性分子为数很少。气态化合物NO由特定的免疫细胞如巨噬细胞释放出来 ,以攻击微生物和肿瘤细胞。它在脑内 A nitric oxide (NO) prodrug called JS K has been shown to selectively kill NO-sensitive leukemia cells without damage to healthy cells. This is expected to be the lead compound for the development of a new generation of anticancer drugs. NO class structure is simple, functional diversity of bioactive molecules few. The gaseous compound NO is released by specific immune cells such as macrophages to attack microorganisms and tumor cells. It’s in the brain